Advertisement
U.S. markets closed

Prime Medicine, Inc. (PRME)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
7.00+0.24 (+3.55%)
At close: 04:00PM EDT
7.05 +0.05 (+0.71%)
After hours: 07:27PM EDT
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Currency in USD

Valuation Measures4

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Upgrade to begin using 40 years of financial statements and get so much more.
 
As of Date: 3/29/2024
Current
12/31/20239/30/20236/30/20233/31/202312/31/2022
Market Cap (intraday)
838.98M862.29M928.24M1.42B1.20B1.81B
Enterprise Value
730.94M714.02M746.07M1.20B930.95M2.09B
Trailing P/E
N/AN/AN/AN/AN/AN/A
Forward P/E
N/AN/AN/AN/AN/AN/A
PEG Ratio (5 yr expected)
N/AN/AN/AN/AN/AN/A
Price/Sales (ttm)
N/AN/AN/AN/AN/AN/A
Price/Book (mrq)
6.304.453.875.11N/AN/A
Enterprise Value/Revenue
N/AN/AN/AN/AN/AN/A
Enterprise Value/EBITDA
-3.92-13.40-14.86-27.21-23.88-55.18

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3-43.09%
S&P500 52-Week Change 327.86%
52 Week High 317.20
52 Week Low 35.54
50-Day Moving Average 37.41
200-Day Moving Average 39.80

Share Statistics

Avg Vol (3 month) 3645.9k
Avg Vol (10 day) 3497.21k
Shares Outstanding 5119.94M
Implied Shares Outstanding 6119.94M
Float 872.44M
% Held by Insiders 125.02%
% Held by Institutions 153.74%
Shares Short (Mar 15, 2024) 49.67M
Short Ratio (Mar 15, 2024) 410.86
Short % of Float (Mar 15, 2024) 419.50%
Short % of Shares Outstanding (Mar 15, 2024) 48.06%
Shares Short (prior month Feb 15, 2024) 410.35M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-43.15%
Return on Equity (ttm)-88.19%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -186.64M
Net Income Avi to Common (ttm)-198.13M
Diluted EPS (ttm)-2.18
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)121.67M
Total Cash Per Share (mrq)1.06
Total Debt (mrq)13.63M
Total Debt/Equity (mrq)10.24%
Current Ratio (mrq)2.53
Book Value Per Share (mrq)1.44

Cash Flow Statement

Operating Cash Flow (ttm)-165.41M
Levered Free Cash Flow (ttm)-96.21M